Kidtrayze

Zinc chloride, potassium iodide, sodium selenite, copper chloride dihydrate, manganese chloride tetrahydrate, the active ingredients in Kidtrayze, is a trace element supplement presented as a solution for injection for intravenous use. It provides essential trace elements to support enzymatic activity and metabolic processes in critically ill or postoperative patients receiving parenteral nutrition.

GNH USA supplies Kidtrayze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and clinics worldwide.

Kidtrayze, a trace element supplement used in parenteral nutrition, is indicated for the following clinical situations:

- Total parenteral nutrition (TPN): ensures adequate trace element provision to support enzymatic functions. - Critical illness: prevents deficiency of essential minerals during severe systemic stress. - Post‑operative recovery: supplies trace elements needed for wound healing and metabolic stability. - Long‑term home parenteral nutrition: maintains trace element balance when oral intake is insufficient.

Kidtrayze may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Infusion site irritation: redness, pain or swelling at the injection site. - Mild nausea or vomiting. - Transient headache. - Metallic taste in the mouth. - Mild electrolyte disturbances (e.g., temporary hypermagnesemia).

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Copper toxicity presenting with hepatic dysfunction. - Zinc toxicity causing gastrointestinal upset and altered copper status. - Selenium toxicity leading to respiratory distress or cardiac effects. - Severe electrolyte imbalance requiring medical intervention. - Neurological symptoms from manganese overload.

Kidtrayze should be used with careful clinical monitoring to minimize risks.

- Baseline assessment: measure serum zinc, copper, selenium, and manganese levels before initiation. - Renal function: adjust use in patients with impaired renal clearance. - Hepatic disease: exercise caution in individuals with liver dysfunction. - Hypersensitivity: avoid in patients with known allergy to any component. - Duration of therapy: limit prolonged use without periodic re‑evaluation of trace element status. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidtrayze may interact with other medications and nutritional products.

Major Interactions (Avoid): - High‑dose copper supplements: increase risk of copper overload. - High‑dose zinc supplements: may precipitate copper deficiency. - Parenteral nutrition regimens containing excessive trace elements: risk of cumulative toxicity. - Chelating agents (e.g., EDTA): can bind trace elements and reduce efficacy. - Heparin‑containing infusion lines: may cause precipitation of metal ions.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: iodide content may affect dosing requirements. - Antioxidant vitamins (C, E): potential interaction with selenium activity. - Renal replacement therapy: may remove administered trace elements, necessitating dose adjustment.